DocGo Inc. announced its partnership with Spect. Leveraging Spect's innovative hand-held retinal cameras, DocGo's mobile health clinicians now have a more scalable and cost-effective way to bring diabetic retinopathy and other eye disease screening services to patients in their own homes and workplaces. Spect's solution was selected as DocGo's preferred solution primarily due to its ease of use, ability to integrate seamlessly into clinical workflows, minimal training curve and availability of a remote Spect specialist to help facilitate the exam.

Spect's platform identifies diabetic retinopathy as well as numerous other eye diseases, such as glaucoma and macular degeneration. The partnership will support DocGo's health plan partnership offerings, with a focus on HEDIS Stars improvement, and mobile primary care. Health plans already contract with DocGo to address gaps in care with in-home medical visits scheduled by DocGo's in-house patient engagement team.

As its preferred solution for diabetic eye exams, DocGo plans to expand its use of Spect devices to help address this critical care gap, as well as explore other opportunities to utilize Spect's solution as part of a comprehensive eye disease screening program.